Literature DB >> 27921403

Prognostic significance of regulatory T lymphocytes in patients with hepatocellular carcinoma.

Ai-Bin Zhang1,2,3,4, Yi-Gang Qian1,2,3,4, Shu-Sen Zheng1,2,3,4.   

Abstract

We investigated the prognostic role of regulatory T cells (Tregs) in patients with hepatocellular carcinoma (HCC). Relevant evidence regarding prognostic significance of Tregs was systematically searched in MEDLINE and Embase databases. A meta-analysis was performed to compare survival in patients with high or low Tregs level (either in peripheral blood or tumor). Eighteen studies were identified that fulfilled for the eligibility criteria and were included for data synthesis. Our pooled hazard ratios (HRs) demonstrated that increased Tregs intratumoral accumulation was significantly associated with worse overall survival (HR=2.04, 95% confidence interval (CI): 1.72-2.42) and disease-free survival (HR=1.82, 95% CI: 1.58-2.09). Three studies evaluated the role of Tregs in peripheral blood, and all of them showed that increased peripheral Tregs correlated with shortened disease-free and overall survival. Collectively, our results showed that the increased Tregs count is tightly associated with the shortened survivals. Its measurement in either primary tumor or even circulation might be a candidate marker of prognostic significance in HCC patients.

Entities:  

Keywords:  Hepatocellular carcinoma; Prognosis; Regulatory T cells

Mesh:

Year:  2016        PMID: 27921403      PMCID: PMC5172602          DOI: 10.1631/jzus.B1600264

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  31 in total

1.  Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection.

Authors:  Min-Jie Ju; Shuang-Jian Qiu; Jia Fan; Yong-Sheng Xiao; Qiang Gao; Jian Zhou; Yi-Wei Li; Zhao-You Tang
Journal:  Am J Clin Pathol       Date:  2009-04       Impact factor: 2.493

2.  Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B.

Authors:  Dongping Xu; Junliang Fu; Lei Jin; Hui Zhang; Chunbao Zhou; Zhengsheng Zou; Jing-Min Zhao; Bin Zhang; Ming Shi; Xilai Ding; Zirong Tang; Yang-Xin Fu; Fu-Sheng Wang
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

3.  Foxp3+ regulatory T cells and the formation of portal vein tumour thrombus in patients with hepatocellular carcinoma.

Authors:  Shun Li Shen; Li Jian Liang; Bao Gang Peng; Qiang He; Ming Kuang; Jia Ming Lai
Journal:  Can J Surg       Date:  2011-04       Impact factor: 2.089

4.  Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

Authors:  Qiang Gao; Shuang-Jian Qiu; Jia Fan; Jian Zhou; Xiao-Ying Wang; Yong-Sheng Xiao; Yang Xu; Yi-Wei Li; Zhao-You Tang
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

5.  Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma.

Authors:  Qiang Gao; Xiao-Ying Wang; Shuang-Jian Qiu; Ichiro Yamato; Masayuki Sho; Yoshiyuki Nakajima; Jian Zhou; Bai-Zhou Li; Ying-Hong Shi; Yong-Sheng Xiao; Yang Xu; Jia Fan
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

6.  FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.

Authors:  Noritoshi Kobayashi; Nobuyoshi Hiraoka; Wataru Yamagami; Hidenori Ojima; Yae Kanai; Tomoo Kosuge; Atsushi Nakajima; Setsuo Hirohashi
Journal:  Clin Cancer Res       Date:  2007-02-01       Impact factor: 12.531

Review 7.  Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.

Authors:  Virginia Hernandez-Gea; Sara Toffanin; Scott L Friedman; Josep M Llovet
Journal:  Gastroenterology       Date:  2013-01-09       Impact factor: 22.682

8.  Immunotherapy of DC-CIK cells enhances the efficacy of chemotherapy for solid cancer: a meta-analysis of randomized controlled trials in Chinese patients.

Authors:  Xiao-peng Lan; You-gen Chen; Zheng Wang; Chuan-wei Yuan; Gang-gang Wang; Guo-liang Lu; Shao-wei Mao; Xun-bo Jin; Qing-hua Xia
Journal:  J Zhejiang Univ Sci B       Date:  2015-09       Impact factor: 3.066

Review 9.  Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis.

Authors:  Stephanie L M Das; Primal P Singh; Anthony R J Phillips; Rinki Murphy; John A Windsor; Maxim S Petrov
Journal:  Gut       Date:  2013-08-08       Impact factor: 23.059

10.  Practical methods for incorporating summary time-to-event data into meta-analysis.

Authors:  Jayne F Tierney; Lesley A Stewart; Davina Ghersi; Sarah Burdett; Matthew R Sydes
Journal:  Trials       Date:  2007-06-07       Impact factor: 2.279

View more
  7 in total

1.  Immune recovery after fluid resuscitation in rats with severe hemorrhagic shock.

Authors:  Feng Yao; Yuan-Qiang Lu; Jiu-Kun Jiang; Lin-Hui Gu; Han-Zhou Mou
Journal:  J Zhejiang Univ Sci B       Date:  2017-05       Impact factor: 3.066

Review 2.  The Peripheral and Intratumoral Immune Cell Landscape in Cancer Patients: A Proxy for Tumor Biology and a Tool for Outcome Prediction.

Authors:  Annette Schnell; Christian Schmidl; Wolfgang Herr; Peter J Siska
Journal:  Biomedicines       Date:  2018-02-24

3.  Loss of alanine-glyoxylate and serine-pyruvate aminotransferase expression accelerated the progression of hepatocellular carcinoma and predicted poor prognosis.

Authors:  Yufeng Sun; Wenchao Li; Shiqi Shen; Xuejing Yang; Bing Lu; Xiaojing Zhang; Peng Lu; Yi Shen; Juling Ji
Journal:  J Transl Med       Date:  2019-11-26       Impact factor: 5.531

4.  Impact of regulatory T cells on the prognosis of hepatocellular carcinoma: A protocol for systematic review and meta analysis.

Authors:  Xinhui Shi; Qisong Li; Yungang Wang
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

5.  Identifying a Novel Endoplasmic Reticulum-Related Prognostic Model for Hepatocellular Carcinomas.

Authors:  Fei Ding; Jinping Li; Yong Zhang; Chengang Wang; Yonghua Yu
Journal:  Oxid Med Cell Longev       Date:  2022-07-22       Impact factor: 7.310

6.  Treg cells in the course of chronic hepatitis C virus infection partially normalize in longitudinal observation after successful DAA treatment regardless of hepatic fibrosis stage.

Authors:  Agata Zientarska; Mariusz Kaczmarek; Iwona Mozer-Lisewska; Arleta Kowala-Piaskowska; Aleksandra Witkowska; Jan Żeromski
Journal:  Clin Exp Hepatol       Date:  2021-06-30

7.  The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma.

Authors:  Cortlandt M Sellers; Johannes Uhlig; Johannes M Ludwig; Jeffrey S Pollak; Tamar H Taddei; Stacey M Stein; Joseph K Lim; Hyun S Kim
Journal:  Cancer Med       Date:  2021-07-28       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.